How do bones heal, and how could they heal better? The answer to these questions may lie in a newly discovered population of “messenger” cells, according to a recent USC Stem Cell study published in the journal eLife. “With nearly half a million patients in the U.S experiencing failed bone repair every year, stimulating these […]
Home »
Engineers aim to pioneer tissue-engineering approach to TMJ disorders: Solutions have been hampered by past failures, proximity of jaw joint to brain
Here’s something to chew on: One in four people are impacted by defects of the temporomandibular — or jaw — joint. Despite the pervasiveness of this affliction, treatments are lacking, and many sufferers resort to palliative measures to cope with the pain and debilitation it causes. “The TMJ is central to chewing, talking and so […]
Moderate muscle strength may lower risk for type 2 diabetes
Of the 30 million Americans with diabetes, 90 to 95 percent have type 2, according to the Centers for Disease Control and Prevention. New research shows building muscle strength may be one way to lower risk for the disease. The study of more than 4,500 adults found moderate muscle mass reduced the risk for type […]
Strategies to protect bone health in hematologic stem cell transplant recipients
Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for many patients with malignant and non-malignant hematological diseases, such as leukemia and multiple myeloma. The success of recent advances in such transplantation techniques and supportive care measures, has led to greater numbers of long-term HSCT survivors. Consequently, an increasing patient population is impacted by […]
New aid to help identify and manage patients with diabetes at increased risk of fracture
Fragility fractures are a serious yet neglected complication of both type 1 and type 2 diabetes, with increased risk of fragility fractures in people with diabetes extending across the life span. This is a concern as, globally, the prevalence of diabetes in adults is expected to increase from almost 425 million today, to approximately 629 […]
Can rare lymphocytes combat rheumatoid arthritis? Immunologists have identified the key role of ILC2 during the onset of inflammatory arthritis
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis. ILCs have several functional similarities to T-cells and are important agents of our congenital immune system. The FAU researchers’ findings could form the basis for new approaches for treating rheumatoid arthritis. […]